Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BIOQUALHedgePath PharmaceuticalsBioanalytical SystemsCleveland BioLabsTenax Therapeutics
SymbolOTCMKTS:BIOQOTCMKTS:HPPINASDAQ:BASINASDAQ:CBLINASDAQ:TENX
Price Information
Current Price$47.25N/A$5.57$1.99$1.21
52 Week RangeN/AN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$42.26 million$24.45 million$61.77 million$21.92 million$8.66 million
Beta0.09-1.160.79-0.371.4
Average Volume8192,23240,9472,100,35734,310
Sales & Book Value
Annual Revenue$39.48 millionN/A$43.62 million$1.14 millionN/A
Price / Sales1.07N/A1.3819.73N/A
CashflowN/AN/A$0.20 per shareN/AN/A
Price / CashN/AN/A27.19N/AN/A
Book ValueN/A($0.01) per share$0.96 per share$0.32 per share$3.10 per share
Price / BookN/A5.806.22N/A
Profitability
Net Income$2.83 million$-4,550,000.00$-790,000.00$-3,610,000.00$-6,810,000.00
EPSN/AN/AN/AN/A($9.04)
Trailing P/E Ratio10.990.00N/AN/AN/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins9.00%N/A-4.45%-241.79%N/A
Return on Equity (ROE)N/AN/A-12.10%-93.20%-162.76%
Return on Assets (ROA)N/A-246.03%-2.90%-69.62%-143.63%
Dividend
Annual Payout$0.70N/AN/AN/AN/A
Dividend Yield1.48%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A1.82%N/A0.02%
Current RatioN/A6.76%0.54%3.87%6.70%
Quick RatioN/A6.76%0.65%3.87%6.70%
Ownership Information
Institutional Ownership PercentageN/AN/A7.80%3.99%17.80%
Insider Ownership Percentage39.24%4.80%11.46%1.88%10.39%
Miscellaneous
EmployeesN/A2224N/A9
Shares Outstanding890,000370.45 million10.82 million11.30 million6.74 million
Next Earnings Date4/21/2020 (Estimated)N/A5/20/2020 (Estimated)3/5/2020 (Estimated)4/6/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel